QUINAZOLINE COMPOUND SERVING AS EGFR TRIPLE MUTATION INHIBITOR AND APPLICATIONS THEREOF
申请人:East China University of Science and Technology
公开号:EP3778586A1
公开(公告)日:2021-02-17
Related to a quinazoline compound serving as an EFGR triple mutation inhibitor and applications thereof. Specifically, disclosed are a compound as represented by the following formula (I), a pharmaceutical composition comprising the compound of formula (I), and applications of the compound in treating a related disease mediated by EGFR and in a medicament for treating the related disease mediated by EGFR.
涉及一种作为EFGR三重突变抑制剂的喹唑啉化合物及其应用。具体地说,公开了如下式(I)所代表的化合物、包含式(I)化合物的药物组合物,以及该化合物在治疗由表皮生长因子受体介导的相关疾病和治疗由表皮生长因子受体介导的相关疾病的药物中的应用。